Precision Based Medicine Requires Precision Based Solutions
A ClearPath To Clinical Trials
The complexity and costs of sample management and the impacts on Clinical Operations, Data and Vendor Management have increased significantly with the rise of precision based medicine.
​
ClearPath Clinical Research has the solution.
Stay tuned! Full website and services release May of 2025.
How is the growing complexity of protocols impacting our clinical trial operations?
How we treat disease is evolving to be more targeted to mechanisms of actions through the power of precision based medicine.
​
The days of PK and Safety Samples being the only samples and data types in primary and secondary endpoints are over. Biomarker strategies, and related data, are now being included.
​
This has resulted in:
​​​
-
Increased number of samples and data collected to test and demonstrate the new protocol endpoints
-
Increased number of lab vendors utilizing novel assays to test biomarkers
-
Increase global logistics and burden on already stressed clinical study teams
-
Addition of new functional groups at Biotech’s and Pharma companies, and their vendors, to meet this demand
​​
All of this places a larger burden on clinical study teams and increased costs to run clinical trials. We believe that there are innovative approaches and software solutions that don't have to add to already overinflated and confusing contracts.
At ClearPath Clinical Research, we've addressed this with cost-effective sample management software and SME-driven Professional Services Solutions across multiple functional areas.
More to come in May of 2025.